Posts filtered by tags: Stéphane Bancel[x]


 

EU's Covid vaccination debacle is down to institutional inflexibility

Supply delays underline there was no legal or economic justification for central planningA storm is raging over the EU’s failure to have ordered more of the approved Covid-19 vaccines ahead of time. Stéphane Bancel, the chief executive of the US pharmaceutical company Moderna, which gained approval for its vaccine shortly after Pfizer/BioNTech, claims that the EU has relied too much on “vaccines from its own laboratories”.Did the European commission prioritise supporting its own pharmaceutical i...
Tags: Europe, Business, China, US, Eu, European Union, UK News, World news, US news, European Commission, Astrazeneca, Pharmaceuticals industry, Vaccines and immunisation, Pfizer, Moderna, Fosun Pharma


Children are the next frontier for COVID vaccine clinical trials

Twelve-year-olds are tween-agers, staring down puberty and middle school, surprisingly mature one minute and tortured by angst the next. Some also are scientific pioneers, volunteering for clinical trials to test COVID vaccines in children. Slowly and gingerly, researchers are testing COVID-19 vaccines in younger and younger kids — even as millions of doses are pushed into the arms of their parents — with an eye toward FDA approval in the next year or two. Stephanie Chao, director of pharmacy...
Tags: Health, News, Medicine, California, Cdc, Stanford, China, India, Los Angeles, Sport, Public Health, Soccer, Healthcare, Vaccinations, Fda, Berkeley


Children the next frontier for COVID vaccine clinical trials

Twelve-year-olds are tween-agers, staring down puberty and middle school, surprisingly mature one minute and tortured by angst the next. Some also are scientific pioneers, volunteering for clinical trials to test COVID vaccines in children. Slowly and gingerly, researchers are testing COVID-19 vaccines in younger and younger kids — even as millions of doses are pushed into the arms of their parents — with an eye toward FDA approval in the next year or two. Stephanie Chao, director of pharmacy...
Tags: Health, News, Medicine, California, Cdc, Stanford, China, India, Los Angeles, Sport, Public Health, Soccer, Healthcare, Vaccinations, Fda, Berkeley


Coronavirus vaccines are safe for people of color, despite online myths and mistrust of the healthcare system

Sandra Lindsay receives the COVID-19 vaccine in New Hyde Park, New York. Mark Lennihan/Pool via REUTERS People of color, and Black Americans in particular, may be hesitant to get vaccinated in the US due to a history of racist medical experiments or overall mistrust of the healthcare system. In Latinx communities, language barriers can also force people to receive health information through social media, where myths abound. But clinical trials overwhelmingly show that coronavirus vaccines...
Tags: UK, Science, News, New York City, US, Trends, New York Times, Native Americans, Philadelphia, Npr, Pfizer, Pew Research Center, People Of Color, Cnbc, Black, Princeton University


The world will have to live with COVID forever - Moderna CEO

Echoing comments from some other public health officials, Moderna (NASDAQ:MRNA) CEO Stephane Bancel said COVID-19 is likely to become an...
Tags: mRNA, Stéphane Bancel, COVID


Moderna CEO says data on the Covid-19 vaccine in young children likely won't be available until 2022

A nurse prepares a coronavirus vaccine shot developed by the National Institutes of Health and Moderna Inc., July 2020. Hans Pennink/AP Hans Pennink/AP Data on Moderna's Covid-19 vaccine in young children won't be available until 2022, CEO says at JPMorgan Healthcare conference. The study will take longer because they have to start at a much lower dose. Studies have already begun in children ages 12 and up. Visit Business Insider's homepage for more stories. Moderna will begin studying the...
Tags: News, Trends, Healthcare, Food And Drug Administration, Pfizer, Vaccine, Disneyland Resort, Centers For Disease Control And Prevention, Jpmorgan, Moderna, JPMorgan Healthcare, Stéphane Bancel, Hans Pennink, Coronavirus, Bancel, COVID-19


Coronavirus live news: WHO warns no herd immunity in 2021; Moderna says vaccine immunity lasts a year

Portugal’s president tests positive; Lebanon tightens restrictions as infections skyrocket; ‘Reckless’ Christmas rule relaxation blamed for Ireland surgeEngland told to prepare for worst weeks of Covid pandemicChina agrees to let in WHO team investigating Covid originsFrench vaccine scepticism reflects ‘dissatisfaction with politicians’See all our coronavirus coverage 12.20am GMT Immunity from Moderna Inc’s Covid-19 vaccine should last at least a year, the company said on Monday at the JP Mo...
Tags: UK News, World news, US news, Ireland, Portugal, Who, World Health Organization, Lebanon, Moderna, JP Morgan Healthcare, Stéphane Bancel, Moderna Inc, Coronavirus, COVID


I volunteered to test the Moderna coronavirus vaccine. Here's what the side effects were like, and why I want my experience to give people hope.

Elle Hardy. Elle Hardy Journalist Elle Hardy is taking part in a phase-three trial of Moderna's mRNA-1273 vaccine, which was just approved in the UK and has been shown to be 94.5% effective. The UK government has ordered 17 million doses of Moderna's shot, but it's unlikely to roll out before March. The shot was approved for use in the US in December. After a slight reaction to the two doses, Hardy said she was certain she didn't receive a placebo. "The side effects were a little unpleasan...
Tags: Health, South Korea, UK, England, Science, News, Instagram, Australia, White House, US, Trends, United States, Healthcare, Oxford, MMR, Vaccine


The US just authorized Moderna's coronavirus vaccine, making millions more doses available to help curb the pandemic

Moderna; Samantha Lee/Business Insider US regulators have authorized a second coronavirus vaccine for emergency use.  This two-dose vaccine, developed by the biotech firm Moderna and the US National Institutes of Health, was about 94% effective at preventing COVID-19 in a large clinical trial. Moderna's vaccine is easier to store and transport than Pfizer's COVID-19 shot, which got US clearance a week ago. Moderna plans to deliver 20 million doses in the US by year's end.  The authorizati...
Tags: Health, Science, News, China, Massachusetts, Russia, US, Trends, United States, Healthcare, Astrazeneca, Fda, Pfizer, University of Oxford, Anthony Fauci, Low


Coronavirus vaccines compared: What to know about shots from Moderna and Pfizer, from safety to side effects

A nurse is inoculated with the Pfizer/BioNTech coronavirus vaccine. REUTERS/Carlos Osorio Both Moderna and Pfizer have provided data to the FDA showing that their shots are safe and effective at preventing COVID-19 infections. But, the shots do have some subtle differences. Moderna's might better protect against severe cases, while Pfizer's seems to have milder side effects. Here's everything you need to know. Visit Business Insider's homepage for more stories. With US regulators releasing...
Tags: UK, US, Trends, South Africa, Fda, Pfizer, Bell, The Food and Drug Administration, Marks, Moderna, Peter Marks, Stéphane Bancel, COVID, Hilary Brueck Andrew Dunn, Carlos Osorio Both Moderna, Vaccinated


The FDA will likely grant Moderna's COVID-19 vaccine emergency use authorization on Friday

A nurse prepares a coronavirus vaccine shot developed by the National Institutes of Health and Moderna Inc., July 2020. Hans Pennink/AP The US Food and Drug Administration will approve the Moderna vaccine on Friday, The New York Times reported. FDA regulators confirmed Moderna's vaccine was 94.1% effective at preventing COVID-19 in late-stage trials, per agency documents released Tuesday. The US bought 200 million doses of Moderna's vaccine as of December 15. Moderna CEO Stéphane Bancel pr...
Tags: Politics, Science, News, White House, US, Trends, New York Times, Healthcare, Oxford, Astrazeneca, Fda, Pfizer, Vaccine, Oxford University, Times, Johnson Johnson


Your complete coronavirus vaccine calendar: When Moderna's candidate is likely to get authorized, and when you could receive your Pfizer shot

Dr. Mustafa Gerek participates in a coronavirus vaccine trial at Ankara City Hospital in Ankara, Turkey on October 13, 2020. Aytac Unal/Anadolu Agency via Getty Images Three companies developing COVID-19 vaccines — AstraZeneca, Moderna, and Pfizer — have released positive results from their late-stage trials. Pfizer's vaccine received emergency authorization from the FDA on Friday, putting it on track to deliver shots as early as Monday. An FDA advisory committee will decide whether to rec...
Tags: UK, Science, News, Cdc, US, Trends, Bloomberg, Food And Drug Administration, Brazil, Astrazeneca, Fda, Npr, Pfizer, University of Oxford, Anthony Fauci, Centers For Disease Control And Prevention


Pfizer's vaccine authorization means 2.9 million high-risk people will get the shot within days - the first step in a 9-month path to normalcy

A nurse prepares to inject staff with the Pfizer/BioNtech COVID-19 vaccine at Bradley Manor residential care home in the UK on December 9, 2020. Liam McBurney/PA Images via Getty Images The FDA has authorized the first coronavirus vaccine in the US, a two-dose regimen from Pfizer and BioNTech. Some frontline healthcare workers and residents of long-term care facilities could receive the shots in as little as 24 hours, likely on Monday. The US could immunize 20 million people by the end of ...
Tags: Utah, UK, New York, Science, News, Mississippi, Washington Post, Kentucky, Brown University, US, Trends, Walgreens, United States, Food And Drug Administration, Fda, Pfizer


Georgia upholds Biden's win as US approaches 15m coronavirus cases - live

Raffensperger: ‘We counted three times and results remain unchanged’US death toll at 283,211 and continues to climbFauci: ‘The middle of January could be a really dark time’Biden prepares for Republicans try to block cabinet picksTrump: Rudy Giuliani has coronavirusSign up to receive First Thing – our daily briefing by email 9.30pm GMT That’s it from me for now. My west coast colleague, Maanvi Singh, will take over the blog for the next few hours.Here’s where the day stands so far: 9.13pm ...
Tags: White House, US, Georgia, World news, Joe Biden, US news, US politics, Pfizer, Biden, Donald Trump, Rudy Giuliani, Trump, Maanvi Singh, Stéphane Bancel, Albert Bourla, Raffensperger


Moderna just asked the FDA to authorize its coronavirus vaccine, a key step before it can be given to more people

Moderna CEO Stéphane Bancel at a meeting with President Donald Trump, members of the White House coronavirus task force, and pharmaceutical executives on March 2. Andrew Harnik/AP Images Moderna filed for emergency-use authorization of its experimental coronavirus vaccine, the company announced on Monday. The biotech company said its vaccine was 94.1% effective against COVID-19 in an analysis of a late-stage trial. If the Food and Drug Administration authorizes the vaccine, the US intends ...
Tags: White House, US, Trends, New York Times, Food And Drug Administration, Astrazeneca, Fda, Pfizer, University of Oxford, Donald Trump, Anthony Fauci, Health And Human Services, US Food and Drug Administration, Fauci, Marks, Moderna


3 coronavirus vaccines so far seem to prevent COVID-19. Here's how their efficacy compares to vaccines for flu, measles, and more.

A healthcare worker injects a patient with the Pfizer and BioNTech coronavirus vaccine during the phase 3 trial in Turkey in October. Dogukan Keskinkilic/Anadolu Agency via Getty Images AstraZeneca reported last week that its coronavirus vaccine candidate was 70% effective, on average, in preventing COVID-19 in clinical trials. Moderna and Pfizer's vaccine candidates were found to be 94% and 95% effective, respectively.  The chart below shows how the efficacy of those vaccine candidates co...
Tags: Health, UK, Science, News, Massachusetts, Trends, Turkey, MMR, Food And Drug Administration, Brazil, Astrazeneca, Fda, Pfizer, University of Oxford, Pascal Soriot, Johnson Johnson


Moderna CEO said he hopes to be vaccinating Americans 'within 24 hours' of an FDA green light

Moderna CEO Stephane Bancel attends a meeting with President Donald Trump, members of the Coronavirus Task Force, and pharmaceutical executives in the Cabinet Room of the White House on March 2, 2020. Andrew Harnik/AP Images Moderna announced it will file for emergency use-authorization with the US Food and Drug Administration on Monday. CEO Stéphane Bancel said the company aims to start vaccinating Americans within "24 hours after the FDA gives an approval." Moderna said the vaccine was 9...
Tags: News, White House, US, Trends, Healthcare, Astrazeneca, Fda, Pfizer, University of Oxford, Donald Trump, Fox Business, Johnson Johnson, US Food and Drug Administration, Department of Health and Human Services, Andrew Harnik, Moderna


Moderna is set to ask the FDA to authorize its coronavirus vaccine, a key step before it can be given to more people

Moderna CEO Stephane Bancel attends a meeting with President Donald Trump, members of the Coronavirus Task Force, and pharmaceutical executives in the Cabinet Room of the White House on March 2, 2020. Andrew Harnik/AP Images Moderna will file today for emergency use authorization of its experimental coronavirus vaccine. The biotech company said the vaccine was 94.1% effective against COVID-19 in an analysis of a late-stage trial. If the FDA authorizes the vaccine, the US intends to start v...
Tags: White House, US, Trends, New York Times, Oxford, Astrazeneca, Fda, Pfizer, Donald Trump, Anthony Fauci, Health And Human Services, Fauci, Marks, Andrew Harnik, Moderna, Azar


Moderna's groundbreaking coronavirus vaccine was designed in just 2 days

Moderna; Samantha Lee/Business Insider Moderna's coronavirus vaccine candidate is 94.5% effective at protecting people against COVID-19, according to the company. The candidate took under a year to develop and test, which is years faster than previous vaccines. The company designed its vaccine candidate in just two days. In contrast, traditional vaccines can take years to design. Visit Business Insider's homepage for more stories. Moderna's coronavirus vaccine candidate was found to be 94...
Tags: China, Trends, Atlantic, New York Times, Astrazeneca, Graham, Fda, Pfizer, Anthony Fauci, Nih, American Lung Association, Rizzo, The Food and Drug Administration, Seattle Washington, Novavax, Wuhan China


Your complete coronavirus vaccine calendar: When candidates are likely to get authorized, and when you could receive your shot

Dr. Mustafa Gerek participates in a coronavirus vaccine trial at Ankara City Hospital in Ankara, Turkey on October 13, 2020. Aytac Unal/Anadolu Agency via Getty Images Three companies developing COVID-19 vaccines — AstraZeneca, Moderna, and Pfizer — have released positive results from their late-stage trials. Pfizer already applied for emergency authorization from the FDA. Its shot could get authorized as early as December 10, then delivered to Americans 24 to 48 hours after that. Here's a...
Tags: UK, US, Trends, Bloomberg, Brazil, Astrazeneca, Fda, Npr, Pfizer, Anthony Fauci, Centers For Disease Control And Prevention, Business Insider, Johnson Johnson, Ankara Turkey, Fauci, EUA


Moderna's CEO sold nearly $2 million of his stock ahead of the company's emergency use vaccine filing. He's now worth $3 billion.

Moderna CEO, Stephane Bancel. Andrew Dunn/Business Insider Moderna CEO Stephane Bancel sold almost $2 million in shares ahead of the company's emergency use authorization filing for its COVID-19 vaccine.Bancel sold a total of 19,000 shares between November 18-19 as part of a predetermined trading plan amended May 21, according to a filing with the SEC.Moderna is the second major drug company to announce success in a late-stage COVID-19 vaccine trial. It expects to file for FDA approval by t...
Tags: Trends, Markets, Billionaires, SEC, Stocks, Fda, Pfizer, Goldman, Pharmaceutical, Pharma Company, Moderna, Healthcare Stocks, Stéphane Bancel, Albert Bourla, Coronavirus, Bancel


Oxford and AstraZeneca's COVID-19 vaccine is considerably cheaper and easier to distribute than either Pfizer's or Moderna's. Here's why.

A half-dose of Oxford-AstraZeneca's COVID-19 vaccine initially could mean we have double the number doses available when it's approved by regulators. Siphiwe Sibeko/Pool via AP The University of Oxford and AstraZeneca's COVID-19 vaccine can be stored at normal fridge temperatures for at least six months. Unlike Pfizer and BioNTech's vaccine, it therefore doesn't require an ultra-cold storage and transport system, making it cheaper to distribute globally. The price per dose is also ...
Tags: Minnesota, US, Trends, Eu, Healthcare, Oxford, Astrazeneca, Pfizer, Vaccine, University of Oxford, Oxford University, Welt am Sonntag, Andrew Pollard, Moderna, Siphiwe Sibeko, Stéphane Bancel


AstraZeneca and Oxford University's vaccine is effective at preventing COVID-19, trial results suggest. Here's everything we know so far.

Screen grab taken from video issued by Britain's Oxford University, showing a person being injected as part of the first human trials in the UK to test a potential coronavirus vaccine, untaken by Oxford University in England, Thursday April 23, 2020 Oxford University Pool via AP On Monday, AstraZeneca and The University of Oxford released results for their large-scale trial, which showed their COVID-19 vaccine was 70% effective.  The Oxford vaccine is administered in two doses at least...
Tags: Europe, UK, England, US, Trends, Ap, Bbc, Britain, South Africa, Astrazeneca, Pfizer, University of Oxford, Oxford University, Agency, BBC Radio, Welt am Sonntag


The vaccine breakthroughs at Moderna and Pfizer are the latest examples of how immigrants have been driving billions in American innovation for decades

Noubar Afeyan, an immigrant from Lebanon, is the co-founder and chairman of Moderna, the company behind one of the most promising potential COVID019 vaccines. Flagship Pioneering Behind both Moderna and the Pfizer-BioNTech potential coronavirus vaccines are a group of incredible scientists, biotech CEOs, and venture capitalists funding the effort — many of whom are immigrants. Business Insider spoke with Moderna cofounder and chairman Noubar Afeyan, an immigrant himself, abou...
Tags: Spacex, Elon Musk, Greece, France, Germany, Russia, US, America, Trends, Tesla, Bloomberg, Turkey, Joe Biden, Mit, Cologne, Canada


Moderna planning to charge governments $25-$37 for its COVID-19 vaccine

https://www.financialexpress.com/lifestyle/health/moderna-to-charge-25-37-for-covid-19-vaccine-ceo/2133774/ Moderna’s CEO Stephane Bancel has announced that they are planning to charge $25-$37 (depending on the quantity ordered) for their Covid-19 vaccine. He was reportedly quoted saying “Our vaccine therefore costs about the same as a flu shot, which is between $10 and $50.”  Moderna had earlier announced that it has developed a new vaccine for Covid-19 and the vaccine was 94.5% effective in pr...
Tags: Business, News, Moderna, Stéphane Bancel, Covid-19 Vaccine


Moderna CEO Warns Vaccines Will Not End Coronavirus Pandemic: ‘We Need Public Health Measures’

Stephane Bancel, the CEO of the pharmaceutical company Moderna, warned on Thursday that advances in vaccine development won’t be enough...
Tags: Moderna, Stéphane Bancel


SoulCycle's top instructors had sex with clients, 'fat-shamed' coworkers, and used homophobic and racist language, insiders say

Hello everyone! Welcome to this weekly roundup of Business Insider stories from co-Editor in Chief Matt Turner. Subscribe here to get this newsletter in your inbox every Sunday.Read on for more on SoulCycle's top instructors mistreating staff, Moderna's research revolution, and Google CEO Sundar Pichai's leadership shift. Bryan R. Smith/Getty; BFA; Olivia Atherton; Skye Gould/Business Insider Hello!We now have two promising coronavirus vaccines, with Moderna's promising results this week...
Tags: Google, Amazon, Hollywood, California, France, China, Trends, Nike, Palo Alto, Larry Page, Atlantic, Sergey Brin, Retail, Silicon Valley, Graham, Pfizer


'Potentially catastrophic': Sen. Chris Murphy sounds the alarm on the Trump administration not briefing the Biden team on COVID-19 vaccine distribution

Chris Murphy. Zach Gibson/Getty Images The Trump administration told senators during a Thursday briefing that their vaccine team has not yet reached out to the Biden camp to begin coordination on vaccine rollout, Sen. Chris Murphy tweeted.  Murphy, who serves on the Senate's Health Education, Labor, and Pensions Committee, called the lack of outreach 62 days before Inauguration Day "potentially catastrophic." Two companies, Pfizer and Moderna, have recently reported promising results from ...
Tags: Politics, Science, Supreme Court, White House, US, Trends, Joe Biden, Connecticut, Commission, Food And Drug Administration, General Services Administration, Fda, Pfizer, Biden, Donald Trump, Clinton


Moderna's CEO says vaccines aren't a 'silver bullet,' people must still social distance and wear masks

Moderna CEO Stephane Bancel attends a meeting with President Donald Trump. Andrew Harnik/AP Images Wearing a mask and social distancing are the "best weapon" to control the virus, according to Moderna CEO Stéphane Bancel. Bancel spoke at the Bloomberg New Economy Forum on Thursday.  Moderna recently announced that its experimental vaccine was 94.5% effective against the new coronavirus. Bancel said in a recent interview with Business Insider that the public will have access to a vaccine by...
Tags: News, US, Trends, Bloomberg, Healthcare, Fda, Anthony Fauci, Chinese Center for Disease Control and Prevention, Moderna, Stéphane Bancel, Bloomberg New Economy Forum, Allana Akhtar, Coronavirus, Bancel, Coronavirus Vaccine, Covid-19 Vaccine


When can I get a coronavirus vaccine?

Jakub Porzycki/NurPhoto via Getty Images Both Moderna and Pfizer have recently delivered promising news that their coronavirus vaccines are highly effective, in large, diverse human trials. But that doesn't mean you're going to be able to get a shot before the end of 2020.  In all likelihood, the first coronavirus vaccines will begin rolling out to frontline workers and vulnerable populations in the last days of 2020, or possibly early 2021. By Memorial Day in late May, it's possible that...
Tags: Science, News, Cdc, White House, US, Trends, Public Health, South Africa, New York Times, Vaccination, Fda, Pfizer, Anthony Fauci, Istanbul, Soweto, Ankara Turkey